NCT04933682View on ClinicalTrials.gov

Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

August 4, 2021

Study Completion Date

August 4, 2021

Conditions
Healthy
Interventions
DRUG

ALXN2050

Oral tablet.

DRUG

Fluconazole

Oral tablet.

DRUG

Rifampin

Oral capsule.

Trial Locations (1)

85283

Clinical Trial Site, Tempe

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY